logo

ALLERGAN I(NYSE:AGN)
Allergan, Inc. is a provider of eye care and specialty pharmaceutical products throughout the world with products in the eye care pharmaceutical, ophthalmic surgical device, over-the-counter contact lens care, movement disorder, and dermatological markets. Its worldwide consolidated revenues are principally generated by prescription and non-prescription pharmaceutical products in the areas of ophthalmology and skin care, neurotoxins, intraocular lenses and other ophthalmic surgical products, and contact lens care products.
# Employees: 8740
Address: 2525 Dupont Drive,Irvine,CA,USA
Phone: 714 246-4500
Fax: 714 246-4971
Website: www.allergan.com
Email:
Sector: Medical
Industry: MED-DRUGS
Executive Officers
David E.I. Pyott (Chmn.; C.E.O.)
Herbert W. Boyer Ph.D. (V. Chmn.)
James F. Barlow (Sr. V.P.; Corp Contr.; Principal Acctg. Off.)
Jeffrey L. Edwards (Exec. V.P.; Fin & Buss. Devpt.; C.F.O.)
Douglas S. Ingram Esq. (Exec. V. P.; Chief Admn. Off.; Gen. Counsl. & Sec.,)
Dividend
Ex-Dividend Date: 11/5/2009
Annual Dividend: $0.20
Current Dividend Yield: $0.34
Dividend Paid (3 months): $0.05
Indicated Dividend: $0.07
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/10/2010
Mean EPS (Next Qtr): $0.77
Mean EPS (Year): $2.77
Mean Estimate(Long Term): $15.15
P/E Ratio(Based on EPS estimate): 21.200
Number of Estimates: 22
Shares Performance
Period AGN Compare to S&P
YTD 45.39 % 20.33 %
4 Weeks 3.33 % 2.22 %
12 Weeks 6.39 % 0.30 %
Shares Information
Analyst Coverage: Y
Avg Volume: 2048472
Shares Outstanding: 304M
Market Cap: $17.82B
52 Week High: $60.29
52 Week Low: $29.65
P/E Ratio: 21.240
PEG Ratio: 1.400
Split: On 6/25/2007 AGN split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: -6.67 %
EPS Growth in Last Year: 7.69 %
Sales Growth in Last Quarter: 0.93 %
Sales Growth in Last Quarter: 3.92 %
Financials
Qtr Book Value: $3.90
Cash Flow/Share: $16.92
Change in Payout Ratio: -0.030
Price/Sales: 4.110
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia